Study design · reviewed 2026-08-17
Placebo, blinding, and randomization
What placebo, double-blind, and randomized mean on a ClinicalTrials.gov record, in plain English. Not medical advice.
Randomization
Randomized means a chance process (not the doctor’s preference that day) assigns you to a group. That is how trials avoid stacking healthier people on the new treatment. You still get monitoring. You do not get to pick the arm if the protocol is randomized.
Placebo
A placebo is a dummy treatment that looks like the study product. Not every trial uses one. Cancer and other serious-illness studies often compare the new treatment with standard care instead of an inactive dummy. The registry DesignAllocation and Masking fields, plus the brief summary, are the source.
Blinding (masking)
Single-blind usually means you do not know the assignment. Double-blind usually means you and the treating team do not know. Unblinded (open-label) means assignments are known. Blinding reduces wishful reporting. It is not a trick; it is a measurement method. Rescue medicines and emergency unblinding rules should be in the consent form.
What we will not claim
PlainTrials will not say you “might get the real drug” as a selling point. We will not estimate your chance of benefit. Those statements are not in the public registry fields we are allowed to rewrite.